{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:44:31Z","timestamp":1758271471474},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ihj.2018.10.415","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T22:16:46Z","timestamp":1542147406000},"page":"S365-S371","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S3","title":["Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention\u2013induced myocardial injury"],"prefix":"10.1016","volume":"70","author":[{"given":"Danish H.","family":"Kazmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paurush","family":"Ambesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiridhar","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopali","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin K.","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2018.10.415_bib1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehi455","article-title":"Peri-procedural myocardial injury: 2005 update","volume":"26","author":"Herrmann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/ehq393","article-title":"Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection","volume":"32","author":"Babu","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9149(01)01606-X","article-title":"Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes","volume":"88","author":"Fuchs","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0735-1097(03)01044-1","article-title":"Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention","volume":"42","author":"Ioannidis","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199403103301003","article-title":"Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I","volume":"330","author":"Adams","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2018.10.415_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archinternmed.2011.2275","article-title":"Troponin criteria for myocardial infarction after percutaneous coronary intervention","volume":"172","author":"Novack","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ihj.2018.10.415_bib7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/euhj.1999.1521","article-title":"Minimal myocardial damage during coronary intervention is associated with impaired outcome","volume":"20","author":"Simoons","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/hc0502.104278","article-title":"Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?","volume":"105","author":"Akkerhuis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.10.415_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ccd.21345","article-title":"Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis","volume":"71","author":"Nienhuis","year":"2008","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2018.10.415_bib10","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib11","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib12","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/CIRCULATIONAHA.109.888297","article-title":"Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies","volume":"121","author":"Hildick-Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.10.415_bib13","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.106.664920","article-title":"Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study","volume":"114","author":"Steigen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.10.415_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.108.808402","article-title":"Randomized study of the crush technique versus provisional sidebranch stenting in true coronary bifurcations: the CACTUS (coronary bifurcations: application of the crushing technique using sirolimus-eluting stents) study","volume":"119","author":"Colombo","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.10.415_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","article-title":"Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts","volume":"105","author":"Baim","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.10.415_bib16","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2007.06.039","article-title":"The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial","volume":"50","author":"Mauri","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.amjcard.2007.03.105","article-title":"Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis","volume":"100","author":"Merla","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12944-015-0095-1","article-title":"Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials","volume":"14","author":"Pan","year":"2015","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ihj.2018.10.415_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ccd.21677","article-title":"Distal myocardial protection with intracoronary beta blocker when added to a GpIIb\/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome","volume":"72","author":"Uretsky","year":"2008","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2018.10.415_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ijcard.2012.04.096","article-title":"Intracoronary followed by intravenous administration of the short-acting b-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention","volume":"167","author":"Park","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehl411","article-title":"Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non urgent percutaneous coronary intervention: a prospective randomized study","volume":"28","author":"Lee","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.amjcard.2011.08.027","article-title":"Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial)","volume":"109","author":"De Luca","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","article-title":"For the CYCLE investigators. Cyclosporine a in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE trial","volume":"67","author":"Ottani","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.108.809723","article-title":"Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial","volume":"119","author":"Hoole","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.10.415_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijcard.2014.03.026","article-title":"Remote ischemic preconditioning reduces peri-procedural myocardial injury in elective percutaneous coronary intervention: a meta-analysis","volume":"173","author":"Zografos","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ihj.2018.10.415_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1185\/030079902125001146","article-title":"Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty","volume":"18","author":"Polonski","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ihj.2018.10.415_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/hrt.2006.107524","article-title":"Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention","volume":"93","author":"Bonello","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2018.10.415_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00129784-200707020-00006","article-title":"Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention","volume":"7","author":"Labrou","year":"2007","journal-title":"Am J Cardiovasc Drug"},{"key":"10.1016\/j.ihj.2018.10.415_bib30","first-page":"205","article-title":"Effects of trimetazidine therapy on left ventricular function after percutaneous coronary intervention","volume":"41","author":"Xu","year":"2013","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.ihj.2018.10.415_bib31","first-page":"473","article-title":"Evaluation of the myocardial protection of trimetazidine during percutaneous coronary intervention: a multi-center randomized and controlled clinical study","volume":"49","author":"Chen","year":"2010","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.ihj.2018.10.415_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.amjcard.2014.04.052","article-title":"Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention","volume":"114","author":"Shehata","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12669\/pjms.292.2937","article-title":"Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention","volume":"29","author":"Lin","year":"2013","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.ihj.2018.10.415_bib34","doi-asserted-by":"crossref","first-page":"e0137775","DOI":"10.1371\/journal.pone.0137775","article-title":"Effect of trimetazidine in patients undergoing percutaneous coronary intervention: a meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ihj.2018.10.415_bib35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.yjmcc.2005.09.012","article-title":"Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury","volume":"39","author":"Argaud","year":"2005","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.ihj.2018.10.415_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1074248415599265","article-title":"Coronary microembolization induces cardiomyocyte apoptosis in swine by activating the LOX-1-dependent mitochondrial pathway and caspase-8-dependent pathway","volume":"21","author":"Liu","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ihj.2018.10.415_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1755-5922.2011.00275.x","article-title":"Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans","volume":"30","author":"Bucci","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ihj.2018.10.415_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehi816","article-title":"Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine\/adenosine triphosphate ratio in patients with heart failure","volume":"27","author":"Fragasso","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2018.10.415_bib39","doi-asserted-by":"crossref","first-page":"e94660","DOI":"10.1371\/journal.pone.0094660","article-title":"Is treatment with trimetazidine beneficial in patients with chronic heart failure?","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483218302803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483218302803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T01:29:32Z","timestamp":1547256572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483218302803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"alternative-id":["S0019483218302803"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2018.10.415","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention\u2013induced myocardial injury","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2018.10.415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}